On 14 August 2025, Yuan Chao, a physician at Shanghai Dermatology Hospital, presented Amorepacific's barrier-care research to the PCHi industry leadership summit. The technology she discussed was already used in AESTURA's ATOBARRIER365 Cream, which the company had begun introducing to Chinese shoppers the previous month. Official online shops, a named local researcher and a later Shanghai exhibition gave the Korean brand several points of entry into its new market.
AESTURA arrived with a product shaped by its move from professional skincare into everyday retail. Amorepacific combined that history with Chinese product testing and the local organisation's research relationships. The commercial introduction therefore had two connected parts: shops where customers could find the range, and a technical explanation of the cream around which it was built. Its first months in China show the parent extending a specialist brand through an existing regional business.
The launch announcement cited more than seven million cumulative cream units through May 2025, including the pre-renewal version. That history gave AESTURA an established lead product for its Chinese introduction. Four named online platforms offered routes to shoppers, while sampling and trial programmes supported the Atobarrier range. Amorepacific's Q3 update subsequently confirmed the opening of official stores.
A Professional Cream Becomes an Everyday Range
The Chinese launch account traced AESTURA's origins to Pacific Pharma in 1982. It identified a moisturising cream introduced in 2008 for people with impaired skin barriers, followed in 2018 by the daily-care 365 range. Olive Young was the starting point for wider retail distribution. The product China received was the result of that transition from a professional setting to an ordinary shopping routine.
The range offered different textures as well as the lead cream. AESTURA described a lighter water cream and a lotion alongside its richer moisturiser, giving shoppers choices within the same barrier-care identity. In the English announcement, ATOBARRIER365 Cream anchored a broader line of companion products. This was a collection organised around one skincare concern, with the established cream providing its most familiar point of introduction.
Chinese Participants Were Involved Before the Launch
Preparation included a twenty-eight-day product evaluation involving thirty-one Chinese women with sensitive skin, conducted from 4 January to 1 February 2024. Amorepacific cited that test in its Chinese product introduction. The limited study underpinned company claims about the cream, with the release explicitly noting that individual results vary.
The locally reported testing sat alongside the brand's Korean history. It gave the Chinese introduction material drawn from Chinese participants well before the first official market announcement. The company explained textures, moisturisation and its ceramide technology in the same account, connecting the product's research identity with the practical experience of using a cream.
That combination was important to the way AESTURA presented itself. Its name and Korean success could attract attention, but the launch communication also had to explain what the product was for. Sensitive-skin care gave the launch a clear organising idea, connecting the brand's identity with the products offered to Chinese shoppers.
The Online Entry Begins in July
Amorepacific announced the entry publicly on 5 August. Its later Chinese technical account dated the start to July and described flagship shops opening progressively on Tmall, Douyin, JD.com and VIP.com. The company said online commerce would offer a direct and convenient way to reach local sensitive-skin consumers.
The Q3 operating update recorded official stores on major platforms and sampling and trial programmes for the Atobarrier line. The introduction had moved into shopping and product use. It also belonged to a broader expansion of AESTURA abroad: the August announcement described the US, Canada and Australia among that year's new markets, following earlier Asian entries.
Tmall, Douyin, JD.com and VIP.com named in the phased entry announced on 5 August 2025.
Source 1Cumulative cream units from launch through May 2025, including the pre-renewal version.
Source 1Yuan Chao Explains the Technology in Shanghai
Yuan's presentation took place at the ninth PCHi industry leadership summit, held in Shanghai on 13-14 August. Amorepacific identified her as a chief physician in Shanghai Dermatology Hospital's skin and cosmetics research department and a new member of its research advisory committee. Her talk addressed sensitive-skin barrier care using a third-generation ceramide retention system.
The company's account connected DermaOn capsules, containing ceramides, cholesterol and fatty acids, with AESTURA's cream. Yuan discussed their development and application as part of the research programme. The named speaker and defined technology gave the launch an identifiable local scientific setting.
Amorepacific's Shanghai research organisation also presented scalp-care work at the summit. AESTURA was entering a market where the parent already maintained technical relationships and communicated across several skincare categories. The new brand could draw on that established presence while building its own product identity.
November Gives the Range a Physical Stage
On 5 November, AESTURA appeared at the China International Import Expo in Shanghai. Amorepacific described this as the first offline unveiling of the brand's entire range, with ATOBARRIER365 Cream at the centre. It joined a seven-brand display as the parent marked its eighth consecutive year at the exhibition.
The showcase also placed the newcomer beside Sulwhasoo, LANEIGE, RYO, INNISFREE, Mamonde and HERA. Chief executive Seunghwan Kim emphasised the company's continuing relationship with Chinese consumers, and Amorepacific participated in a Tmall Global signing ceremony. The event extended the digital introduction into a physical presentation within the parent's established Chinese programme.
Across those months, the same cream connected the stores, sampling, technical presentation and exhibition. AESTURA's entry developed from online shopping and trial programmes into an in-person range presentation. The wider Chinese portfolio was being reworked at the same time, giving the newcomer an organisation that was already adjusting how it served the market.
DSML research · 8 October 2026 · Revised 31 October 2026


